KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹590 Cr | ₹446 Cr | ₹394 Cr | ₹354 Cr | ₹341 Cr |
What is the latest Total Liabilities ratio of KWALITY PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹590 Cr |
| Mar2025 | ₹446 Cr |
| Mar2024 | ₹394 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹341 Cr |
How is Total Liabilities of KWALITY PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹590 Cr | 32.32 | |
| Mar2025 | ₹446 Cr | 13.06 | |
| Mar2024 | ₹394 Cr | 11.47 | |
| Mar2023 | ₹354 Cr | 3.83 | |
| Mar2022 | ₹341 Cr | - | |
Compare Total Liabilities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹3,671.7 Cr | -4.1% | 0.5% | 305.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | -4.1% |
0.5% |
305.2% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses